Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of......
The COVID-19 pandemic took a deadlier and more devastating turn in 2021 soon after a glimmer of hope was provided by the launch of vaccines at the beginning of the year, etching nightmarish......
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global......
Indian companies have made acquisitions of $1 billion so far in January Outbound acquisitions by Indian companies have seen a surge in the first month of 2017 after a lull for the past three......
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft. From reducing dwell time at airports to faster......
One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions, report Sohini Das &......
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments. The next......